If only 2 get approved it’s enough to have the company sold in 2 years. But once we get past BE equivalent I think we are good even if the FDA requires the company to address something. Worst case should be delays and maybe a bit high cost to go to market. If success hinged on one particular needle mover I wouldn’t be as confident. But I am also not borrowing money so buy shares and am only buying more at prices lower than this now (because I have several million at avg of about 7 cents)
News 
Market Data 
Discover 
